Evaluation of oestrogen receptor β wild-type and variant protein expression, and relationship with clinicopathological factors in breast cancers
- 31 December 2002
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 38 (3) , 380-386
- https://doi.org/10.1016/s0959-8049(01)00383-5
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Cancerfonden
This publication has 16 references indexed in Scilit:
- Clinical value of the wild-type estrogen receptor β expression in breast cancerCancer Letters, 2001
- Immunolocalisation of oestrogen receptor beta in human tissuesJournal of Molecular Endocrinology, 2000
- Expression of estrogen receptor α exon 5 and 7 deletion variant in human breast cancersBreast Cancer, 2000
- Cloning and Characterization of Human Estrogen Receptor β IsoformsBiochemical and Biophysical Research Communications, 1998
- Estrogen receptor-β mRNA variants in human and murine tissuesMolecular and Cellular Endocrinology, 1998
- The Complete Primary Structure of Human Estrogen Receptor β (hERβ) and Its Heterodimerization with ER αin Vivoandin VitroBiochemical and Biophysical Research Communications, 1998
- Identification of a splice variant of the rat estrogen receptor β geneMolecular and Cellular Endocrinology, 1997
- ERβ: Identification and characterization of a novel human estrogen receptorFEBS Letters, 1996
- Cloning of a novel receptor expressed in rat prostate and ovary.Proceedings of the National Academy of Sciences, 1996
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991